31 completed, 11 unknown, 5 terminated, 4 recruiting. 57 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 57 | Completed 31, Unknown 11, Terminated 5, Recruiting 4, Withdrawn 3, Active not recruiting 2, Not yet recruiting 1 |
Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Parenteral Ascorbic Acid Repletion in TransplantatIon Ascorbic acid, Placebo - Liver Transplant Failure and Rejection | Phase 4 | Withdrawn | University of Wisconsin, Madison | 2026-09-01 | 2026-09-18 | |
| Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants CNS Stimulant, Placebo, CNS Stimulant open label first phase - ADHD - Attention Deficit Disorder With Hyperactivity, Irritability | Phase 4 | Recruiting | Milton S. Hershey Medical Center | 136 | 2026-03-05 | 2026-04-20 |
| Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia Paliperidone Palmitate Injection (PP1M) - Schizophrenia | Phase 4 | Not yet recruiting | Jiangsu Province Nanjing Brain Hospital | 120 | 2025-10-01 | 2025-09-29 |
| The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically Adderall 10Mg Tablet, Placebo - Prescription Stimulants, Expectations | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2025-07-01 | 2025-04-07 | |
| Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids. - Kidney Transplantation | Phase 4 | Recruiting | University Hospital, Antwerp | 20 | 2024-08-20 | 2024-08-21 |
| Empagliflozin Treatment in Kidney Transplant Recipients Empagliflozin - Kidney Transplant, Chronic Kidney Disease | Phase 4 | Recruiting | VA Office of Research and Development | 264 | 2024-04-05 | 2026-04-21 |
| Body and Social Behavior Influenza vaccine, Placebo - Psychology, Social, Inflammation | Phase 4 | Completed | University of North Carolina, Chapel Hill | 104 | 2022-10-17 | 2024-11-27 |
| Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Metformin Extended Release Oral Tablet - Breast Cancer Stage, Insulin Resistance | Phase 4 | Withdrawn | Woman's | 2022-09-01 | 2023-07-06 | |
| Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) Grafalon, Normal Treatment - Kidney Transplant Failure and Rejection | Phase 4 | Active not recruiting | Fundación Canaria Instituto de Investigación Sanitaria de Canarias | 80 | 2022-07-05 | 2026-09-08 |
| Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR Twice-daily Tacrolimus, Once-daily envarsus XR, Induction Immunosuppression with Basiliximab or Rabbit Anti Thymoglobulin (rATG) - Kidney Transplantation, Kidney Transplant Rejection | Phase 4 | Terminated | University of Southern California | 20 | 2021-11-23 | 2025-11-10 |
| Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) Experimental: GLP1-RA (exenatide) administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus | Phase 4 | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 42 | 2021-09-13 | 2026-01-20 |
| Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) Experimental: CRH administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus | Phase 4 | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 52 | 2021-07-06 | 2024-04-03 |
| Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome Guanfacine Extended Release, Placebo - Prader-Willi Syndrome, Aggression | Phase 4 | Completed | Maimonides Medical Center | 15 | 2020-12-17 | 2024-08-19 |
| Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients Basiliximab 20 milligram [Simulect], Normal Saline - Kidney Transplantation | Phase 4 | Unknown | King Faisal Specialist Hospital & Research Center | 140 | 2020-09-01 | 2021-02-18 |
| Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients Extended-release tacrolimus, Immediate-release tacrolimus - Kidney Transplant Rejection | Phase 4 | Completed | Cedars-Sinai Medical Center | 20 | 2020-01-09 | 2024-07-10 |
| Allograft Dysfunction in Heart Transplant Regadenoson - Heart Transplant Failure and Rejection | Phase 4 | Recruiting | Paul Kim | 376 | 2019-10-01 | 2026-05-01 |
| Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle? Letrozole 2.5mg - Investigative Techniques, Reproductive Techniques | Phase 4 | Unknown | National Taiwan University Hospital | 300 | 2019-04-25 | 2020-04-29 |
| Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients Blonanserin, MRI and serum BDNF - First Episode Schizophrenia, Social Function | Phase 4 | Terminated | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 102 | 2019-01-22 | 2024-04-19 |
| Envarsus XR® in Adolescent Renal Transplant Recipients Envarsus XR, Tacrolimus - Kidney Transplantation, Renal Transplantation | Phase 4 | Active not recruiting | University of California, Los Angeles | 28 | 2019-01-15 | 2023-02-09 |
| Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Dydrogesterone 10 MG Oral Tablet, Progesterone Vaginal Gel [Crinone] - Infertility, Female, Infertility, Male | Phase 4 | Unknown | Memorial Sisli Hospital, Istanbul | 140 | 2019-01-02 | 2019-10-14 |
Showing 20 of 57. Sign in to see all of them.
Rejection, Psychology (22) · Aggression (17) · Attention Deficit Disorder with Hyperactivity (6) · Helping Behavior (6) · Oppositional Defiant Disorder (4) · Psychomotor Agitation (4) · Schizophrenia (4) · Behavior (3) · Insulin Resistance (3) · Psychotic Disorders (3) · Social Adjustment (3) · Alzheimer Disease (2) · Combined Pituitary Hormone Deficiency (2) · Conduct Disorder (2) · Cytomegalovirus Infections (2)
Behavior (54) · Mental Disorders (18) · Aberrant Motor Behavior in Dementia (17) · Behavioral Symptoms (17) · Pathological Conditions, Signs and Symptoms (12) · Neurodevelopmental Disorders (10) · Nervous System Diseases (8) · Signs and Symptoms (8) · Urogenital Diseases (8) · Attention Deficit and Disruptive Behavior Disorders (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Brain Diseases (6) · Central Nervous System Diseases (6)
Tacrolimus (9) · Risperidone (7) · Mycophenolic Acid (6) · Sodium Chloride (4) · Sirolimus (3) · Basiliximab (2) · Guanfacine (2) · Magnetic Resonance Spectroscopy (2) · Metformin (2) · Methylphenidate (2) · Methylprednisolone (2) · Paliperidone Palmitate (2) · Saline Solution (2) · Tablets (2) · Valproic Acid (2)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (3) · Columbia University (2) · New York State Psychiatric Institute (2) · Northwestern University (2) · Armenteros, Jorge L., M.D., P.A. (1) · Augusta University (1) · Bayside Health (1) · Cedars-Sinai Medical Center (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Erasme University Hospital (1) · Erasmus Medical Center (1) · Fundació Sant Joan de Déu (1) · Fundación Canaria Instituto de Investigación Sanitaria de Canarias (1) · Hospital do Rim e Hipertensão (1) · IVI Barcelona (1)
United States (26) · Spain (9) · Belgium (5) · Canada (2) · China (2) · United Kingdom (2) · Australia (1) · Brazil (1) · Germany (1) · Israel (1) · Lebanon (1) · Netherlands (1) · Saudi Arabia (1) · Taiwan (1) · Turkey (Türkiye) (1)
Anna Aulinas, MD PhD (2) · Adam G McLean, MA DPhil (1) · Adnan Sharif, MD (1) · Aida Farreny, PhD Psycho. (1) · Alison Berent-Spillson, PhD (1) · Cynthia Harper-Weinstein (1) · Daniel Abramowicz, PhD (1) · Davangere P. Devanand, MD (1) · David A Baran, MD (1) · David Knight, PhD (1) · Deepan Singh, MD (1) · Donna L Londino, MD (1) · Doron Gothelf, professor (1) · E. Steve Woodle, MD (1)
PMID 11693758, PMID 11943259, PMID 16890123, PMID 17917554, PMID 17919618, PMID 18551063, PMID 19284612, PMID 19671625, PMID 20413602, PMID 20643330, PMID 21216835, PMID 21476613, PMID 21555100, PMID 21737072, PMID 21962016, PMID 23075176, PMID 24290461, PMID 24355800, PMID 24457279, PMID 24552218, PMID 25910661, PMID 25988935, PMID 26745211, PMID 27855483, PMID 29898210, PMID 31576513, PMID 32007604, PMID 32528650, PMID 3308166, PMID 33988338, PMID 35443947, PMID 36094829, PMID 36344929, PMID 37526194, PMID 39824923, PMID 42101960
2015 (2), 2008 (1), 2009 (1), 2014 (1), K01MH095920 (1), R01AG021488 (1), R01MH072912 (1)